Genzyme sues Dr Reddy's over Mozobil generic; Germany agrees to boost price on MS drug Sativex;

@FiercePharma: Big Pharma pressures U.K. officials on cancer drug use as special fund set to expire. More from PMLiVE | Follow @FiercePharma

@EricPFierce: market is growing rapidly but so is the number of drugs approved to treat it. Novartis gets in. Story | Follow @EricPFierce

> Sanofi's ($SNY) Genzyme unit sued Indian generics maker Dr. Reddy's Laboratories to defend its patents on the cancer drug Mozobil. Report

> GW Pharmaceuticals said German pricing authorities agreed to a new, higher price for Sativex, a treatment for multiple sclerosis symptoms. Report

> Perrigo recruited a former FDA official to head up its regulatory review activities. Report

> Supernus Pharmaceuticals ($SUPN) designated Catalent Pharma Solutions as its supplier for delayed-release technology employed in a recently launched epilepsy treatment. Report | More from FierceCRO

> The United Nations said there has been dramatic progress in the worldwide fight against AIDS, thanks to the growing availability of treatment. Report

Medical Device News

@FierceMedDev: Veracyte, a molecular diagnostic company, has filed plans for an IPO. Story | Follow @FierceMedDev

@DamianFierce: FDA device chief Jeffrey Shuren blogs about "landmark" UDI rule. More | Follow @DamianFierce

@MarkHFierce: RainDance, a maker of gene-sequencing tools, raised up to $35M in debt financing to keep the sales push going. Article | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Bind collects $70.5M IPO to support Accurin tech. More from FierceDrugDelivery | Follow @MichaelGFierce

> SafeShot pulls in $9M to develop better pre-filled syringes. More

> AdvaMed: Medical device prices have plunged. News

> Report: Med tech industry on growth track despite obstacles. Item

Biotech News

@FierceBiotech: ICYMI Friday: San Diego biotech insider accused of shooting RNAi expert and brother-in-law. Article | Follow @FierceBiotech

@JohnCFierce: Perlmutter has been working hard to create a new narrative for R&D. More efficient, smarter, focused on winners. Legacy bites again. | Follow @JohnCFierce

@EmilyMFierce: NIH launches $45M Alzheimer's research effort, awards funds to 3 preclinical studies. Story from FierceBiotech Research | Follow @EmilyMFierce

> Biotech public records spur 'arms race' for investors. Article

> Merck R&D hammered by another setback as FDA rejects anesthesia drug (again). Story

> Roche lung cancer drug bags another 'breakthrough' at the FDA. News

> Ablynx lands $840M AbbVie deal on next-gen Humira successor. Article

CRO News

> Quintiles seals deal for Novella. News

> PPD lures UCB exec to head immunology. Report

> Capsugel expands in U.S., Europe. Item

> CMO Aesica puts up $48M to make diabetes drugs. Article

> Catalent lands manufacturing deal with Supernus. More

> InVentiv partners up for policy, site selection. Story

Biotech IT News

> BRAIN Initiative prioritizes better data storage and analysis. More

> Biotech broker fined $5,000 for venting on Facebook. Item

> FDA posts final guidance on electronic source data. Story

> Google hires ex-Genentech CEO to lead ambitious bio spinoff. Report

> Bioinformatics-driven Eisai subsidiary inks discovery alliance. News

> New York Genome Center opens $54M biomedical-research hub. Article

And Finally... Homeless patients have sued Nevada, saying the state mental hospital shipped them out of state to avoid paying for their care. Report (sub. req.)